Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 13;68(5):5687-5698.
doi: 10.1021/acs.jmedchem.4c02952. Epub 2025 Feb 20.

Chemoproteomic Profiling of a Carbon-Stabilized Gold(III) Macrocycle Reveals Cellular Engagement with HMOX2

Affiliations

Chemoproteomic Profiling of a Carbon-Stabilized Gold(III) Macrocycle Reveals Cellular Engagement with HMOX2

Sailajah Gukathasan et al. J Med Chem. .

Abstract

In this work, we discovered a novel organometallic gold(III) macrocycle, Au-Mac1, that demonstrates anticancer potency in a panel of triple-negative breast cancer cells (TNBC), and based on this complex, a biotinylated-Au-Mac1 probe was designed for target identification via chemoproteomics, which uncovered the engagement of HMOX2 of the heme-energy metabolism pathway. Using orthogonal chemical biology and molecular biology approaches, including immunoblotting, flow cytometry, and cellular thermal shift assays, it was confirmed that Au-Mac1 engages HMOX2 in cells. Downstream effects of Au-Mac1 on the depletion of mitochondrial membrane proteins and bioenergetics point to the potential role of HMOX2 in cancer. Importantly, Au-Mac1 inhibits in vivo tumor growth of metastatic breast tumor-bearing mice. We believe that this approach is clinically relevant in network-oriented drug discovery. To the best of our knowledge, Au-Mac1 is the first gold complex that targets HMOX2 to elicit an anticancer effect.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The authors declare the following competing financial interest(s): S.G.A. has patents pending to University of Kentucky Research Foundation. S. G.A. serves on the advisory board and is Chief Executive Officer of Ayarissa Biosciences.

References

    1. Mertens RT, Gukathasan S, Arojojoye AS, Olelewe C & Awuah SG Next Generation Gold Drugs and Probes: Chemistry and Biomedical Applications. Chem Rev (2023). - PMC - PubMed
    1. Shaw CF Gold-Based Therapeutic Agents. Chemical Reviews 99, 2589–2600 (1999). - PubMed
    1. Bartlett N Relativistic effects and the chemistry of gold. Gold Bulletin 31, 22–25 (1998).
    1. Schwerdtfeger P, Dolg M, Schwarz WHE, Bowmaker GA & Boyd PDW Relativistic effects in gold chemistry. I. Diatomic gold compounds. The Journal of Chemical Physics 91, 1762–1774 (1989).
    1. Das A, Das U & Das AK Relativistic effects on the chemical bonding properties of the heavier elements and their compounds. Coordination Chemistry Reviews 479(2023).

MeSH terms

LinkOut - more resources